Misonix has entered into a new, three year distribution agreement with Hemax Medical, based in Hvidovre, Denmark, for the distribution of the BoneScalpel Ultrasonic Bone Cutter. The agreement provides Hemax Medical with the rights to sell BoneScalpel in Denmark, Norway, and Sweden, and includes minimum purchase requirements.
Misonix said that the BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue, while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument without the potential hazards associated with rotary sharps.
Michael McManus, president and chief executive officer of Misonix, said: “Misonix welcomes Hemax Medical to our expanding sales and distribution organization in Europe. Hemax comes to us with an established reputation as a top tier distributor of advanced medical equipment in Scandinavia.”
Misonix is a developer of minimally invasive ultrasonic medical device technology, which in Europe, is used for the ablation of tumors and worldwide for other acute health conditions such as wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications.
Hemax Medical is a distributor of medical devices and capital equipment, with special emphasis on neuro and spine surgery.